Vivitrol Provider Locator Agreement

Use the supplier`s Locator tool below to find a doctor near you who can discuss vivitrol. If you are a health professional and would like to be listed as a provider, please download the form. IMPORTANT: The registration and participation of health care providers at the provider Locator is voluntary and free and, with the specific information of the provider in the provider`s locator, is based exclusively on the responses of health care providers. Inclusion in the Locator Provider does not involve any recommendation, recommendation or approval by Alkermes, Inc. We recommend that you search for each provider`s registration information, qualifications and experience before confirming an appointment. Alkermes is responsible to you or anyone for any decision or action you take by trusting this information. Note on Forward-Looking Statements Certain statements contained in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, but not limited to declarations, the entity`s expectations of its activities, plans and prospects, including its plans to develop the VIVITROL and ARISTADA supplier network, as well as its ability to support uninterrupted access to its medicines through other means. The Company cautions that forward-looking statements are inherently uncertain. While the Company considers these statements to be based on reasonable assumptions as part of its knowledge of its business and business activities, forward-looking statements are neither promises nor guarantees and are necessarily subject to a high degree of uncertainty and risk. Actual results may differ materially from those expressed or implied in the forward-looking statements, due to differing risks and uncertainties; among other things: the effects of the COVID-19 pandemic and efforts to mitigate their spread to the company`s activities, including the effects on suppliers or distribution channels of its supply chain, the effects on health systems related to opioid dependence, alcohol and schizophrenia addiction, as well as access to company drugs by patients and health care providers, the effects on services related to the use of its products and their effects on the U.S., Irish and/or global economies. and the risks and uncertainties associated with the “Risk Factors” sub-heading in the Company`s Management Report on Form 10-K for 31 The Company`s Quarterly Report on Form 10-Q for the quarter ending March 31, 2020 and subsequent corporate notifications to the U.S. Securities and Exchange Commission (“SEC”) are available on the SEC`s website at www.sec.gov.

Existing and potential investors are cautioned not to improperly rely on these forward-looking statements, which are made only as of the date of this statement.